Company
LB PHARMACEUTICALS INC (LBRX)
Standardized SEC financial data for LB PHARMACEUTICALS INC — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001691082 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-8.4%
Free cash flow
-$35.3M
Current ratio
41.45×
EPS (diluted)
$-3.13
Income statement
| USD | FY2024 | FY2025 |
|---|---|---|
| R&D expense | $51.2M | $16.7M |
| SG&A expense | $13.7M | $13.7M |
| Pretax income | -$63.1M | -$25.2M |
| Income tax | $1K |
Balance sheet
| USD | FY2023 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | — | $25.4M | — | $295.2M |
| Total current assets | — | $28.9M | — | $308.4M |
Cash flow
| USD | FY2024 | FY2025 |
|---|---|---|
| Operating cash flow | -$53.1M | -$35.2M |
| Capital expenditures | $769K | $52K |
| Free cash flow | -$53.8M | -$35.3M |
| Investing cash flow | $23.2M |
Get LBRX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LBRX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LBRX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"